Metformin May Lower Diabetics’ Odds for Pancreatic Cancer (HealthDay)

HealthDay - SUNDAY, Aug. 2 (HealthDay News) — Metformin, one of the most
widely used diabetes drugs, may offer patients the added benefit of
lowering their odds for pancreatic cancer by 60 percent, a new study
shows.

This entry was posted on Monday, August 3rd, 2009 at 3:37 pm and is filed under Health. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.